Glyrova CV 20 Tablet 10's
₹219.1*
MRP ₹249
12% off
(Inclusive of all Taxes)
GetFREE deliveryon this order with circle membership
Provide Delivery Location
Glyrova CV 20 Tablet is used to prevent heart attack and stroke in the future. It lowers the raised level of cholesterol and fats (triglycerides) in our body. A heart attack is a condition in which your coronary arteries (blood vessels supplying blood and oxygen to the heart) become blocked due to the build-up of fats (plaque), including cholesterol. These plaques narrow the arteries, leading to atherosclerosis and coronary artery disease, mainly for most heart attacks.
Glyrova CV 20 Tablet is composed of two medicines, Rosuvastatin and Clopidogrel. Rosuvastatin is a lipid-lowering medication that blocks the enzyme required to make cholesterol in the body. As a result, it lowers the bad cholesterol (low-density lipoproteins or LDL), triglycerides (TG) and increases the levels of good cholesterol (high-density lipoproteins or HDL). Clopidogrel is a blood thinner (anticoagulant) that collectively prevents a clot in the blood vessels. Together, Glyrova CV 20 Tablet reduces the increased levels of bad cholesterol (low-density lipoprotein and triglycerides) and prevents blood clots, thereby reducing and preventing the risk of heart attack, stroke and heart-related chest pain (angina).
Take Glyrova CV 20 Tablet exactly as directed by your doctor. The dose and duration of Glyrova CV 20 Tablet may differ depending on the reason why you're taking it and your responses to treatment. In some cases, you may experience headaches, ankle swelling due to fluid retention (oedema), slow heart rate, and nausea. Glyrova CV 20 Tablet is known to cause dizziness, so driving should be avoided. Most of these side effects of Glyrova CV 20 Tablet do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
Try not to stop taking Glyrova CV 20 Tablet of your own. Suddenly, stopping Glyrova CV 20 Tablet may worsen your condition and increase your risk of a future heart attack. Inform your doctor if you are allergic to rosuvastatin or clopidogrel or have any active liver disease (liver enzyme abnormalities), active bleeding issues (like peptic ulcer, brain haemorrhage), or muscle problem (myopathy, rhabdomyolysis). The patient should inform the doctor that they are taking Glyrova CV 20 Tablet before any surgery is scheduled or any new medicine is taken. Rosuvastatin, present in Glyrova CV 20 Tablet , is a pregnancy category X drug, so it should not be given to pregnant women. It may cause harm to the fetus if administered to pregnant or breastfeeding women.
Rosuvastatin is a lipid-lowering medication that blocks the enzyme required to make cholesterol in the body. As a result, it lowers the bad cholesterol (low-density lipoproteins or LDL) and triglycerides (TG) and increases the levels of good cholesterol (high-density lipoproteins or HDL). Clopidogrel is a blood thinner (anticoagulant) that collectively prevents a clot in the blood vessels. Together Glyrova CV 20 Tablet reduces the increased levels of bad cholesterol (low-density lipoprotein and triglycerides) and prevents blood clots, thereby reducing the risk of heart attack, stroke, and heart-related chest pain (angina).
Stomach bleeding
Gastrointestinal bleeding
Nose bleeding
Rash
Diarrhoea
Stomach ulcer
Muscle disease (myopathy, rhabdomyolysis)
Abdominal pain
Tell your doctor if you are allergic to rosuvastatin, clopidogrel, or any of its ingredients. If you have any active liver disease, active bleeding issues (like peptic ulcers, brain haemorrhage), pregnant, or plan to become pregnant or breastfeeding, do not take Glyrova CV 20 Tablet until prescribed. The patient should inform the doctor that they are taking Glyrova CV 20 Tablet before any surgery is scheduled or any new medicine is taken. Rosuvastatin present in Glyrova CV 20 Tablet is a pregnancy category X drug, so it is contraindicated in pregnant women. As it may cause harm to the fetus if administered to pregnant women. The risk of muscle problems might increase if Glyrova CV 20 Tablet is taken with an antibiotic (clarithromycin), anti-HIV drugs (ritonavir, lopinavir, darunavir, atazanavir, indinavir) and antifungal (itraconazole). Coadministration with anticoagulants like warfarin may cause gastric bleeding and other bleeding problems. So, if you are using any blood-thinning agents, let your doctor know about this. Glyrova CV 20 Tablet contains rosuvastatin, which can cause muscle problems like myopathy and rhabdomyolysis. Patients with active liver disease should use the Glyrova CV 20 Tablet with caution. Safety and effectiveness of Glyrova CV 20 Tablet have not been established, so its use should be avoided in paediatric patients less than ten years of age. Discontinuation of Glyrova CV 20 Tablet may lead to cardiovascular events like heart attack, stroke, and angina (heart-related chest pain). Hence, you should consult a doctor before stopping the dose of Glyrova CV 20 Tablet .
Drug-Drug Interactions: Glyrova CV 20 Tablet may interact with antibiotics (erythromycin, clarithromycin), anti-HIV drugs (ritonavir, lopinavir, darunavir, atazanavir, indinavir) and antifungal (itraconazole), blood thinners (warfarin, heparin), anti-arthritis drug (colchicine), oral contraceptives, heart-related medicine (digoxin) and immune system affecting drug (cyclosporine).
Drug-Food Interactions: Alcoholic beverages and grapefruit or its juice intake should be avoided with Glyrova CV 20 Tablet as it may interact with Glyrova CV 20 Tablet to produce unpleasant side effects like muscle problems and bleeding disorder.
Drug-Disease Interactions: Glyrova CV 20 Tablet should not be given to the patients with active liver disease, active bleeding issues (like peptic ulcer, brain haemorrhage), muscle problems or musculoskeletal problems (myopathy, rhabdomyolysis), asthma, and purpura (blood leakage under the skin).
A low cholesterol diet and a regular exercise regime effectively complement treatment with Glyrova CV 20 Tablet .
Heart attack: Heart attack is when your coronary arteries (blood vessels supplying blood and oxygen to the heart) become blocked due to the build-up of fats (plaque), including cholesterol. These plaques narrow the arteries, leading to atherosclerosis and coronary artery disease, mainly for most heart attacks.
Stroke: Stroke occurs when the blood and oxygen supply to the brain is blocked or minimized. As a result, the brain tissue is deprived of getting oxygen and nutrients. After a few minutes, brain cells (neurons) start to die. A stroke is a medical emergency; immediate treatment is required; it can cause brain damage, coma or even death.
Atherosclerosis: Atherosclerosis occurs when fats, cholesterol, and other substances known as plaque deposit on your artery walls and restrict blood flow. This plaque formation triggers blood clots, narrows the artery's size, and hardens it. This, in turn, can lead to various heart complications like atherosclerosis, heart attack, heart-related chest pain (angina), and stroke. However, it can also affect the body's arteries apart from the heart.
Alcohol
Unsafe
Glyrova CV 20 Tablet should not be taken with alcohol as it may worsen your liver condition with increased secretion of liver enzymes like transaminase. Keep your doctor informed if you drink alcohol.
Pregnancy
Unsafe
Glyrova CV 20 Tablet contains Rosuvastatin, which is a pregnancy category X medicine. It may cause harm to both the pregnant mother and the fetus. Hence, it is not recommended for pregnant women and those who are planning for a pregnancy. Your doctor might prescribe you only in an extreme case.
Breast Feeding
Caution
Take Glyrova CV 20 Tablet only when prescribed, it is known to pass on in a limited quantity via breast milk to the child.
Driving
Caution
Drive with caution, Glyrova CV 20 Tablet usually causes blurry vision and may affect driving ability.
Liver
Caution
Glyrova CV 20 Tablet to be taken with caution, especially if you have a history of liver diseases/conditions. The dose may have to be adjusted by your doctor.
Kidney
Caution
Glyrova CV 20 Tablet to be taken with caution, especially if you have a history of kidney diseases/conditions. The dose may have to be adjusted by your doctor.
Children
Caution
Glyrova CV 20 Tablet is not recommended for children below the age of 10 years. The safety and effectiveness of Glyrova CV 20 Tablet have not been established in children due to limited testing of Glyrova CV 20 Tablet on children by competent authorities worldwide.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Customers Also Bought
Product Substitutes
Recommended for a 30-day course: 3 Strips